Taro Pharmaceutical Industries Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of TARO for the last quarter is 164.94 M USD, and it's 4.96% higher compared to the previous quarter. The net income of Q4 23 is 15.08 M USD.